Premas Biotech develops breakthrough biotech platforms and Gene-to-IND solutions, accelerating vaccines, biologics & drug discovery through global partnerships.
Joined October 2009
- Tweets 273
- Following 38
- Followers 286
- Likes 21
159 Photos and videos
Pinned Tweet
30 Oct 2021
We are thrilled to announce that Oravax Medical Inc. a joint venture between Premas Biotech and US based Oramed Pharmaceuticals has received clearance from the South African Health Products Regulatory Authority to commence Phase 1 clinical trials, for its oral COVID-19 vaccine.
3
6
17
Premas Biotech retweeted
Today we celebrate the incredible molecule that carries the blueprint of life โ DNA โ and the science that helps us decode its secrets.
From understanding human evolution to improving healthcare, our research continues to shape the future of medicine and society.
We are committed to decode lifeโs most powerful language and tunring it into real-world impact.
@BricDbt @DBTIndia @DrJitendraSingh @rajesh_gokhale
@DrSagarSengupta #DNADay #genomics #DNA #biomedicalresearch #CancerGenomics #Populationgenomics #ScienceForSociety #research
3
5
112
Premas Biotech retweeted
We were pleased to host representatives from Premas Biotech for an interaction focused on exploring potential areas of collaboration, identifying shared interests and complementary strengths. It was encouraging to see strong alignment in our vision towards advancing biotechnology and translating research into real-world impact.
We look forward to establishing meaningful partnership with them as we move ahead.
@DBTIndia @BricDbt @DrJitendraSingh @rajesh_gokhale @DrSagarSengupta @PremasBiotech
3
7
169
8 Jun 2023
#WorldBrainTumorDay
Together, we can make a difference!
Premas Biotech #Team unites and wishes strength to all the combatants of #BrainTumour, and to their families and friends.
Let us all stand together for a future with better treatments and improved outcomes for all.
142
8 Jun 2023
When biology, technology and brilliant minds converge under one networking umbrella, ideation, collaboration & advancements in biotech sector happen.
A glimpse of our participating leaders Dr Prabuddha Kundu, Dr Nupur Mehrotra and Vivek Chandraย in action at #BIO2023, Booth 2945.
2
223
6 Jun 2023
Premas has developed GMP CRM197, a polysaccharide vaccine carrier using the technology licensed from NRC Canada, through its JV with Glycovax - Espoir Therapeutics. Espoir will focus on development of bio-generic and novel vaccines for infectious diseases.
See you at #BIO2023.
2
151
5 Jun 2023
We are here at ๐๐ข๐จ ๐๐ง๐ญ๐๐ซ๐ง๐๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐จ๐ง๐ฏ๐๐ง๐ญ๐ข๐จ๐ง!
Meet Dr. Prabuddha Kundu, Dr. Nupur Mehrotra and Vivek Chandra to learn more about our breakthrough technologies and vaccine development.
#vaccines #boston #biopharmaceuticals #innovation #BIO2023 #partner
3
162
3 Jun 2023
Backed by proprietary technologies for difficult-proteins expression system, coupled with PD and manufacturing capabilities for rapid scale up, Premas is able to deliver functional proteins, forย therapeutics drugs, antibodies, and vaccines.
See you at #Bio2023 in Boston!
1
108
2 Jun 2023
At #Bio2023, Premas is showcasing our anti PD-L2 targeting MAb, which has exciting functional data. Our proprietary tech platform was screened to generate the MAb. Looking for collaboration and in-licensing opportunities to accelerate your antibody pipeline -come see us.
1
99
31 May 2023
At Bio, Premas is showcasing our thermo-stable mRNA-VLP vaccine and therapeutic platform.ย
If you are looking for collaboration and in-licensing opportunities to accelerate your vaccine and therapeutic candidates that are easy to scale up and are thermo stable, come see us.
80
30 May 2023
Premas is participating in ๐๐ข๐จ ๐๐ง๐ญ๐๐ซ๐ง๐๐ญ๐ข๐จ๐ง๐๐ฅ ๐๐จ๐ง๐ฏ๐๐ง๐ญ๐ข๐จ๐ง, starting on 5th of June in Boston. Do drop by to see us at ๐๐จ๐จ๐ญ๐ก 2945!
#biointernational #boston #biopharmaceuticals #antibody #collaboration #innovation
90
29 May 2023
Shivani Singh joins #PremasBiotech as Head of HR.
With 17 years of diverse experience in various sectors, she will lead and develop the future HR roadmap, collaborating closely with the Senior Management Team. We welcome Shivani to the Premas family and wish her the best!
1
2
125
11 May 2023
Technology has the power to transform lives and it's a privilege for us to be part of a mission that leverages technology to advance human healthcare and functional protein initiatives.
Hereโs wishing you all a well-meaning National Technology Day!
#NationalTechnologyDay
1
93
27 Apr 2023
๐๐จ๐ซ๐ฅ๐ ๐๐ฆ๐ฆ๐ฎ๐ง๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐๐๐๐ค, aims to highlight the collective action needed to protect people from vaccine-preventable diseases. Our latest vaccine technology involves co-expressing mRNA and VLP in host cell for a vaccine with dual specificity immune response.
85
10 Apr 2023
We had a great time at #WorldVaccineCongress.
Thank you everyone who came by the booth to visit us. It was a pleasure to meet you all.
#vaccines #partnership #collaboration #washingtondc
2
105
5 Apr 2023
Tomorrow is the last day of #WorldVaccineCongress and if you're coming, be sure to not miss our own Co-founder and Managing Director,ย Dr. Prabuddha Kundu's interesting presentation on "Rapid Development of Lyophilized VLP - Nucleic Acid Vaccines".
#innovation #vaccines
1
78
5 Apr 2023
Premas introduces another breakthrough technology: Co-expressing mRNA and VLP in host cell for a vaccine with dual specificity immune response.
To learn more, visit us at booth 321 at the #WorldVaccineCongress 2023 in Washington, D.C.
#technology #biopharmaceuticals #Vaccines
73
4 Apr 2023
Premas is a single-stop shop for your Polysaccharide Vaccine development and manufacturing.
To learn more, visit us at booth 321 at the #WorldVaccineCongress 2023 in Washington, D.C.
#biopharmaceuticals #manufacturing #washingtondc #vaccines #innovation #collaboration
90
3 Apr 2023
Premas uses its proprietary yeast-based D-CryptTM platform that promises rapid engineering, consistent scale-up and manufacturability.
Meet us at booth 321 at the #WorldVaccineCongress, Washington, D.C., to learn more about our vaccine technologies.
#engineering #vaccines
2
81
1 Apr 2023
Premas is bringing its vaccine development technologies to #WorldVaccineCongress2023. Visit us at Booth 321 to learn how you can accelerate your VLP, VLP mRNA or Polysaccharide Vaccines, through partnership with us.
#development #vaccines #biopharmaceuticals #washington
73